Metoclopramide Hydrochloride Svp Pharma

Metoclopramide, the active ingredient in Metoclopramide Hydrochloride Svp Pharma, is a dopamine antagonist presented as an injectable solution for intramuscular and intravenous use. It is employed to control nausea, vomiting and to improve gastric emptying in adult patients under medical supervision.

GNH USA supplies Metoclopramide Hydrochloride Svp Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance. Our distribution network ensures timely delivery across EU and other global markets.

Metoclopramide is used to manage conditions related to nausea, vomiting and delayed gastric emptying.

Nausea and vomiting: Reduces episodes of acute or chemotherapy‑induced nausea and vomiting. Gastroparesis: Improves gastric motility and accelerates stomach emptying in diabetic or idiopathic gastroparesis. Migraine‑associated nausea: Alleviates nausea accompanying migraine attacks. Post‑operative nausea: Prevents nausea and vomiting after surgical procedures. Radiation therapy nausea: Controls nausea during radiation treatment.

Metoclopramide may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Drowsiness: mild sedation or fatigue. - Restlessness: feeling of inner tension or agitation. - Diarrhea: loose stools. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Extrapyramidal symptoms: involuntary muscle movements or dystonia. - Tardive dyskinesia: persistent, irreversible facial or tongue movements. - Neuroleptic malignant syndrome: rare life‑threatening reaction with fever and rigidity. - Severe allergic reaction: rash, itching, swelling, or anaphylaxis.

Before prescribing Metoclopramide, clinicians should consider several safety measures.

Assess neurological history: evaluate for Parkinson’s disease or movement disorders before initiating therapy. Limit duration: avoid use beyond 12 days to reduce risk of tardive dyskinesia. Monitor electrolytes: check potassium and magnesium levels in patients with gastrointestinal disturbances. Use caution in renal impairment: dose may need adjustment in reduced kidney function. Pregnancy and lactation: consider risk‑benefit; use only if clearly needed. Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Metoclopramide can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticholinergic agents: may diminish pro‑kinetic effect of metoclopramide. - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): increase plasma concentrations, raising risk of side effects. - Other dopamine antagonists (e.g., antipsychotics): additive risk of extrapyramidal reactions.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., opioids, benzodiazepines): may enhance sedation. - Serotonergic drugs (e.g., ondansetron, SSRIs): potential for serotonin syndrome. - Diuretics: may exacerbate electrolyte imbalances affecting cardiac function.